Announced today by VICHY Laboratoires, the VICHY EXPOSOME GRANT will promote and encourage research activity on the skin exposome. One research grant of 15 000 € will be awarded annually to a research project proposal in the field of exposome and skin.
What is exposome?
The human body is subjected to and responds to complex exposures throughout the lifespan, including exposures from the environment, diet, lifestyle. For this highly complex interaction, the term exposome was recently coined by Dr. Christopher Wild at the World Health Organization‘s International Agency for Research on Cancer.
The exposome analysis, therefore, complements the human genome by providing a comprehensive description of individuals’ lifelong environmental exposures. Exposome research aims to look at the holistic view of the human body’s exposures, how the body responds to those exposures, and their combined effects.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7751451-vichy-announces-exposome-grant/
Lithium Technologies today announced the winners of the fifth annual Lithium Digital Customer Excellence Awards, affectionately known as the Lithys. This year’s awards set a new record for submissions with 66 entries from 17 countries across four continents and representing 47 brands. The 2015 Lithys also had a big impact on Lithium’s own community, generating more than 21,000 page views and 9,000 visits—and adding 4,000 community members during the voting period. Winners were determined by community votes, outside judges Nate Elliott from Forrester Research and Jim Storer of The Community Roundtable, and Lithium executives.
To view the Multimedia News Release, go http://www.multivu.com/players/English/7522751-lithy-2015-winners/
Visit: http://www.SanjayCPatel.com ~ God Is Real - The Stunning NEW Convergence of Science and Spirituality. Over 100 New Proofs of God from the Bible, Ancient Yoga, and Modern Science!
Finally, after centuries of search, the holy grail of all proofs demonstrating God is real has arrived. Whether you are interested in proof of God for yourself or a skeptical teenager, these new discoveries proving God is real will forever change the way you view the ancient scriptures of Israel and their metaphorical descriptions of our world. It turns out that the ancient metaphors were not ad hoc. They had a deeper meaning and were meticulously modeled.
Hugely important, some of them have been published in three international science journals -- the gold standard of scientific research -- and hailed by many as one of the most important discoveries of this century.
By Sanjay C. Patel Visit http://www.SanjayCPatel.com
Blood cancers are the third leading cause of cancer deaths in the U.S. However, many Americans are unaware of the impact of these cancers, including leukemia, lymphoma and myeloma, which affect the bone marrow, the blood cells, the lymph nodes and other parts of the lymphatic system.
A new survey commissioned by The Leukemia & Lymphoma Society (LLS) reveals more than four in five adults (82%) are surprised that blood cancers are the third leading cancer killer of Americans. Further, nearly four in five adults (78%) are surprised that acute lymphocytic leukemia (ALL) is the most common cancer in children and young adults under age 20.
To view the multimedia release go to:
https://www.multivu.com/players/English/8128551-lls-blood-cancer-awareness-month/
New Orleans is one of the country’s most culturally, architecturally, and musically interesting cities. It will serve as the picturesque backdrop for Team Challenge, the Crohn’s & Colitis Foundation of America’s (CCFA) endurance training and fundraising program, to take over the city on February 28, 2016 for the Rock ‘n’ Roll New Orleans Marathon, Half Marathon & 10k.
For the first time ever, Team Challenge is recruiting for participants to run through the Big Easy while raising critical funds and awareness of Crohn’s disease and ulcerative colitis. Collectively known as inflammatory bowel diseases (IBD), Crohn’s disease and ulcerative colitis are painful, medically incurable diseases that attack the digestive system. There are more than 1.6 million Americans living with these chronic, debilitating diseases.
“Team Challenge provides people with an opportunity to raise critical research dollars while training to do something that, for many people, they never imagined they’d be able to do,” said Craig Comins, vice president of Team Challenge. “It is inspiring to see a group of people come together, some who have these diseases and some who do not, united in the mission of finding a cure for Crohn’s disease and ulcerative colitis.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7512652-ccfa-team-challenge-recruit-nola/
A new test program by the Insurance Institute for Highway Safety (IIHS) rates the performance of front crash prevention systems to help consumers decide which features to consider and encourage automakers to speed adoption of the technology. The rating system is based on research by the Highway Loss Data Institute (HLDI) indicating that forward collision warning and automatic braking systems are helping drivers avoid front-to-rear crashes.
Volvo delivers a unique combination of performance and efficiency with the High Performance Drive-E Powertrain Concept - a triple boost 2-liter 4-cylinder petrol engine with no less than 450 hp.
Following the successful introduction of Volvo’s Drive-E Powertrain range in 2013, Volvo’s powertrain team once again demonstrates its technological leadership in emission-reducing turbo technology.
“When we launched the Drive-E powertrain family, our aim was to deliver the most advanced 4-cylinder engines in the industry based on emissions and fuel consumption relative to performance and drivability. We knew that 320 hp in our petrol configuration was just a starting point. The 450 hp High Performance Drive-E Powertrain Concept, demonstrates this ambition and the versatility of the Drive-E Powertrains,” says Dr. Peter Mertens, Senior Vice President for Research and Development at Volvo Car Group.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/72762550-volvo-reveal-drive-e-450hp-engine/
Miral and SeaWorld Entertainment, Inc. (NYSE:SEAS) (“SeaWorld”) today announced their partnership to develop SeaWorld Abu Dhabi, a first-of-its-kind marine life themed park on Yas Island. This next generation SeaWorld Abu Dhabi will also include the United Arab Emirates’ (“UAE”) first dedicated marine life research, rescue, rehabilitation and return center with world-class facilities and resources for the care and conservation of local marine life. SeaWorld Abu Dhabi will be the first new SeaWorld without orcas, and will integrate up-close animal experiences, mega attractions and a world class aquarium, bringing the latest technology in visitor engagement.
The partnership brings together Miral’s expertise in developing Yas Island’s portfolio of destinations with SeaWorld’s 50-plus years of theme park, veterinary medicine, marine science and zoological practice and experience.
To view the multimedia release go to:
http://www.multivu.com/players/uk/8002251-miral-announces-seaworld-yas-island/
While January 1 is the traditional day millions announce their New Year’s Resolutions, research shows only 8% of Americans achieve success. For the fifth year, Life Time, is aiming to help people rethink resolutions and instead make a true, internal commitment to themselves to living a healthy way of life by participating in the Commitment Day 5K Fun Run and Walk. Held at more than 40 Life Time destinations across the U.S. and Canada, Commitment Day empowers individuals, families and communities to start the year on the right foot by marking their pledge with action toward a year of better health. New for 2017, a Virtual 5K is available for anyone in North America to join in. All participants will receive a race bib and commemorative Commitment Day tee shirt. Registration, locations and pricing details are available at www.CommitmentDay.com.
Commitment Weekend kicks off on Friday, Dec. 30 and continues through Monday, Jan. 2, when Life Time will open its doors to everyone – whether a member or not. During each of the four days, Life Time’s 122 destinations will feature a variety of health and fitness experiences and activities for all ages. In addition to the 5K Fun Run and Walk on Jan. 1, people can take part in unique-to-Life Time group fitness, indoor cycle and yoga classes such as Strike, Amp Cycle and Warrior Sculpt, as well as Alpha Training. Life Time’s indoor aquatic centers, basketball courts, rock walls and tennis, racquetball and squash courts will all be open with club-specific programming to help men, women and kids make their commitment even easier by doing activities they love or trying new things that will inspire them in the coming year.
To view the multimedia release go to:
http://www.multivu.com/players/English/7991951-life-time-commitment-day-virtual-5k-fun-run-walk/
As businesses become increasingly frustrated by shelf-life hardware and out-of-the-box software, hosted solutions have grown increasingly popular, with 81% of corporates already using or planning to use cloud-based services according to recent research.
42% of SMEs who subscribed to hosted services did so in the last 12 months, showing the swift emergence of cloud solutions.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62395-TalkTalk-business-hosting-solutions
Federally funded research that provides a deep understanding of cancer is spurring advances against many types of the disease. With a strong bipartisan commitment from Congress to keep investment in biomedical research a national priority, we can accelerate our pace of progress and save more lives from cancer, according to the seventh annual American Association for Cancer Research (AACR) Cancer Progress Report, released today.
Basic research in the fields of immunology and cancer genetics has recently been harnessed to develop two new forms of cancer treatment: immunotherapy and precision medicine. As detailed in the report, the utility of these treatments is expanding rapidly. In May 2017, the U.S. Food and Drug Administration (FDA) heralded a new dawn for precision medicine when it approved the immunotherapeutic pembrolizumab (Keytruda) for treating patients with any solid tumor harboring specific genetic characteristics. This is the first anticancer therapeutic approved based on cancer biomarkers rather than the location in the body where the cancer originated.
To view the multimedia release go to:
https://www.multivu.com/players/English/8155051-aacr-cancer-progress-report-2017/
Make sure you do your research before
posting non-sensical comments! EMs a great rapper, but lacks example
and if you look deeper he is simply about money...at any cost! Women,
Kids, Family, Friends...all targets! He preys on the weak and wants no
part of a true solidier! And for the record this is hardly a
diss.
